T1	Participants 440 524	patients with abnormal screening tests in a medically underserved patient population
T2	Participants 691 742	993 eligible subjects with abnormal screening tests
T3	Participants 1426 1543	Participant demographics included 72% minority, 49% with annual household income less than $10,000, and 36% uninsured
T4	Participants 246 293	low-income, uninsured, and minority populations
